Lives Of Lung Cancer Patients May be Extended By Preventing Lung Scarring
Oct 31st 2007Drug InformationLung Cancer
Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients — pulmonary fibrosis (scarring of the lungs), thereby extending patients’ [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
